Orion - Changes in company's own shares

Orion Oyj : Transfer of 119,326 own B-shares on 3 March 2014

ORION CORPORATION        STOCK EXCHANGE RELEASE 3 MARCH 2014 at  6.55 p.m.  EET



Transfer of 119,326 own B-shares on 3 March 2014

In accordance with a decision by the Board of Directors, Orion Corporation has
on 3 March 2014 transferred altogether 119,326 Orion Corporation B-shares held
by the company as a share reward for earning periods 2011-2013 and 2013 to the
persons employed by the Orion Group and belonging to the Share-based Incentive
Plans of the Orion Group. The transfer is based on the authorisation by the
Annual General Meeting of 19 March 2013. The price per share of the transferred
shares is EUR 23.4802, which is the volume weighted average quotation of the
Orion Corporation B-share on 3 March 2014. Accordingly, the total transaction
price of the transferred shares is EUR 2,801,798.35.

After the share transfer, the total number of own B-shares held by Orion
Corporation is 569,665.

Orion Corporation has informed about the Share-based Incentive Plans in stock
exchange releases on 18 February 2010 and 5 February 2013.




Orion Corporation



 Timo Lappalainen      Olli Huotari
 President and CEO     SVP, Corporate Functions








Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi


Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. Pharmaceutical R&D focuses on central nervous system drugs,
oncology and critical care drugs, and Easyhaler® pulmonary drugs.

Orion's net sales in 2013 amounted to EUR 1,007 million and the company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki.

[HUG#1765888]